Top Markets
Coin of the day
Vetoquinol S.A. Vetoquinol S.A.

Vetoquinol S.A.

VETO
Rank in Stocks #9672
Vetoquinol S.A. is a prominent veterinary pharmaceutical enterprise dedicated... Vetoquinol S.A. is a prominent veterinary pharmaceutical enterprise dedicated to the innovation, development, and global commercialization of both medicinal and non-medicinal solutions for animal health. Its operations extend across Europe, the Americas, and the Asia Pacific regions. The company's diverse product portfolio addresses crucial therapeutic areas, including mobility, pain management, and inflammation; dermatological care and hygiene; anti-parasitic treatments; udder health; infectious disease control; reproductive solutions; behavior modification; internal medicine; and cardiovascular-renal support. These offerings cater to a wide spectrum of animals, encompassing livestock such as cattle, sheep, pigs, and poultry, alongside companion animals like dogs. Founded in 1933, Vetoquinol S.A. is headquartered in Lure, France, and functions as a subsidiary of Soparfin SCA.
Share Price
$83.27
Last synced: 2026-08-28
Market Cap
$967.96M
Change (1 day)
-0.85%
Change (1 year)
-5.99%
Country
FR
Trade Vetoquinol S.A. (VETO)

Category

Earnings for Vetoquinol S.A. (VETO)
Earnings in 2026 TTM: 0
According to Vetoquinol S.A. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Vetoquinol S.A. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors